Meissner, W., Argoff, C., Sator, S., Schoder, V., & Karst, M. (2025). VER-01 Shows Enhanced Gastrointestinal Tolerability, Superior Pain Relief, and Improved Sleep Quality Compared to Opioids in Treating Chronic Low Back Pain: A Randomized Phase 3 Clinical Trial. Pain & Therapy, 14(6), 1765-1782. https://doi.org/10.1007/s40122-025-00773-z
Chicago-Zitierstil (17. Ausg.)Meissner, Winfried, Charles Argoff, Sabine Sator, Volker Schoder, und Matthias Karst. "VER-01 Shows Enhanced Gastrointestinal Tolerability, Superior Pain Relief, and Improved Sleep Quality Compared to Opioids in Treating Chronic Low Back Pain: A Randomized Phase 3 Clinical Trial." Pain & Therapy 14, no. 6 (2025): 1765-1782. https://doi.org/10.1007/s40122-025-00773-z.
MLA-Zitierstil (9. Ausg.)Meissner, Winfried, et al. "VER-01 Shows Enhanced Gastrointestinal Tolerability, Superior Pain Relief, and Improved Sleep Quality Compared to Opioids in Treating Chronic Low Back Pain: A Randomized Phase 3 Clinical Trial." Pain & Therapy, vol. 14, no. 6, 2025, pp. 1765-1782, https://doi.org/10.1007/s40122-025-00773-z.